This article first appeared on GuruFocus .
Divi's Laboratories Ltd ( NSE:DIVISLAB ) is set to release its Q2 2026 earnings on Nov 7, 2025. The consensus estimate for Q2 2026 revenue is $25.86 billion, and the earnings are expected to come in at $22.90 per share. The full year 2026's revenue is expected to be $106.26 billion, and the earnings are expected to be $95.32 per share. More detailed estimate data can be found on the Forecast page.
Divi's Laboratories Ltd ( NSE:DIVISLAB ) Estimates Trends
-
Warning! GuruFocus has detected 7 Warning Signs with NSE:DIVISLAB.
-
Is NSE:DIVISLAB fairly valued? Test your thesis with our free DCF calculator.
Over the past 90 days, revenue estimates for Divi's Laboratories Ltd have declined from $106.86 billion to $106.26 billion for the full year 2026 and from $125.85 billion to $125.37 billion for 2027. Similarly, earnings estimates have decreased from $96.12 per share to $95.32 per share for 2026 and from $120.87 per share to $119.88 per share for 2027.
Divi's Laboratories Ltd ( NSE:DIVISLAB ) Reported History
In the previous quarter ending on June 30, 2025, Divi's Laboratories Ltd's actual revenue was $24.10 billion, which missed analysts' revenue expectations of $24.56 billion by -1.86%. The actual earnings were $20.49 per share, missing the earnings expectations of $20.85 per share by -1.73%. Following the release of these results, Divi's Laboratories Ltd's stock was down by -4.3% in one day.
Divi's Laboratories Ltd ( NSE:DIVISLAB ) 12 Month Price Targets
Based on the one-year price targets offered by 24 analysts, the average target price for Divi's Laboratories Ltd is $6,314.58, with a high estimate of $7,750 and a low estimate of $4,098. The average target implies a downside of -7.20% from the current price of $6,804.50.
Based on GuruFocus estimates, the estimated GF Value for Divi's Laboratories Ltd in one year is $6,087.54, suggesting a downside of -10.54% from the current price of $6,804.50.
Based on the consensus recommendation from 25 brokerage firms, Divi's Laboratories Ltd's average brokerage recommendation is currently 2.9, indicating a "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
